Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

NOVARTIS

Filed by CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2025
Income
$50,000.00
Expenses
Not reported
Client
NOVARTIS
Filing UUID
faf16c02-e46c-4e82-a68f-b42598ac1362
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Support for H.R. 1672 - Maintaining Investments in New Innovation Act (MINI Act)

Literal federal measure citations: H.R. 1672

MMM · Medicare/Medicaid

Support for H.R. 1672 - Maintaining Investments in New Innovation Act (MINI Act)

Literal federal measure citations: H.R. 1672

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.